THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01640639
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 100 participants
- Registry
-
NCT01640639
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Italy
- Registry status
- Unknown status
Technical summary
Registry record NCT01640639. Randomized; quadruple masking; primary purpose treatment. Start 2012-07 (registry gives no type); primary completion 2013-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure
- Acronym
- THUNDER
- Condition
- Congestive Heart Failure
- Intervention (Drug)
- Thalidomide
- Intervention (Drug)
- Placebo
- Lead sponsor
- University of Roma La Sapienza
Record details
- Record id
cardio:ct-nct01640639- Content hash
6ad76e62b505ff3c7662195cc62d7bcbee673a885b1a9b2907487b38a03de605